81 withdrawn. 81 Phase 2, 14 Phase 1, 9 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 81 | Withdrawn 81 |
| Phase 1 | 14 | Withdrawn 14 |
| Phase 3 | 9 | Withdrawn 9 |
Follow Hypersensitivity: new trials by email Literature Review of Hypersensitivity trials Research Report on Hypersensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis Ivermectin Pill - Atopic Dermatitis | Phase 2 | Withdrawn | Stanford University | 2030-12-01 | 2024-12-02 | |
| Preventing Childhood Asthma Using Prophylactic House Dust Mite Allergen Immunotherapy HDM sublingual Immunotherapy, Placebo - Asthma, Allergy | Phase 2 | Withdrawn | Boston Children's Hospital | 2027-02-01 | 2024-11-26 | |
| Ritlecitinib (PF-06651600) in Participants With Chronic Spontaneous Urticaria Ritlecitinib - Chronic Spontaneous Urticaria, CSU | Phase 2 | Withdrawn | Ahuva D Cices | 2025-12-31 | 2025-12-09 | |
| Investigation of the Efficacy of Metformin Therapy on Pulmonary Sarcoidosis Metformin, Cellulose - Sarcoidosis, Pulmonary | Phase 2 | Withdrawn | University of Maryland, Baltimore | 2025-12-10 | 2025-02-11 | |
| Pragmatic RCT of High-dose Oral Montelukast for Moderate and Severe Pediatric Acute Asthma Exacerbations Montelukast Oral Granules - Asthma; Status, Asthma in Children | Phase 2 | Withdrawn | Vanderbilt University Medical Center | 2025-09-01 | 2024-11-18 | |
| Tyrosine Kinase 2 (TYK2) for GA and CS Deucravacitinib - Sarcoidosis, Granuloma Annulare | Phase 2 | Withdrawn | Yale University | 2025-03-01 | 2025-04-29 | |
| Analysing HIgh Dose Probiotic Peanut Oral Immunotherapy (PPOIT) and High Dose Peanut Oral Immunotherapy (OIT) Versus LOw Dose Peanut OIT for Peanut Allergy Peanut Oral Powder [PEANUT POWDER], Probiotic (LGG®, Lactobacillus Rhamnosus) or placebo probiotic (maltodextrin) - Peanut Allergy | Phase 2 | Withdrawn | Murdoch Childrens Research Institute | 2024-05-01 | 2024-09-19 | |
| Terbutaline Sulfate in Adults With Asthma Terbutaline - Asthma | Phase 2 / Phase 3 | Withdrawn | Kanecia Obie Zimmerman | 2023-07-07 | 2026-01-22 | |
| Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone Naltrexone, Placebo - Atopic Dermatitis, Pruritus | Phase 2 | Withdrawn | University of Minnesota | 2022-12-31 | 2023-04-04 | |
| A Study of MTPS9579A in Participants With Refractory Chronic Spontaneous Urticaria MTPS9579A, Placebo - Chronic Spontaneous Urticaria | Phase 2 | Withdrawn | Genentech, Inc. | 2022-07-31 | 2022-11-18 | |
| 129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study Hyperpolarized Xe129 - Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis | Phase 2 | Withdrawn | University of Kansas Medical Center | 2022-05-01 | 2022-09-10 | |
| A Study of Topical BX005-A in Subjects With Moderate to Severe Atopic Dermatitis BX005-A, Placebo - Atopic Dermatitis | Phase 1 / Phase 2 | Withdrawn | BiomX, Inc. | 2022-05-01 | 2025-08-03 | |
| Efficacy and Safety of GNR-038 vs Berinert® in Patients With Hereditary Angioedema GNR-038, 50 МЕ/ kg, GNR-038, 100 МЕ/ kg, Berinert®, 20 МЕ/ kg - Hereditary Angioedema | Phase 2 / Phase 3 | Withdrawn | AO GENERIUM | 2021-12-01 | 2022-02-04 | |
| STEP-IT-UP - Peanut Allergy Study for Infants Peanut powder or peanut butter - Peanut Allergy, Food Allergy | Phase 2 | Withdrawn | Johns Hopkins University | 2021-11-01 | 2021-11-17 | |
| Evaluating Effects of Curcumin in Moderate to Severe Asthmatics Curcumin, Placebo - Asthma | Phase 2 | Withdrawn | Loma Linda University | 2021-09-01 | 2021-11-17 | |
| Study to Evaluate the Efficacy, Safety, and Tolerability of Tirabrutinib in Participants With Antihistamine-Resistant Chronic Spontaneous Urticaria Tirabrutinib, Placebo - Chronic Spontaneous Urticaria | Phase 2 | Withdrawn | Gilead Sciences | 2021-07-01 | 2021-07-28 | |
| Pharmacokinetics, Efficacy, Tolerability and Safety of Different Budesonide Oral Gel Doses in Adults' Subjects of Both Genders With Eosinophilic Esophagitis (EoE) Budesonide Gel - Eosinophilic Esophagitis | Phase 2 | Withdrawn | Bazell Pharma AG | 2021-04-23 | 2024-08-23 | |
| Novel Treatment for Patients With Peanut Allergy: Intralymphatic Immunotherapy Peanut allergen - Food Allergy Peanut | Phase 1 / Phase 2 | Withdrawn | Scripps Health | 2021-03-01 | 2022-11-22 | |
| Treatment of Chronic Itch in Atopic Dermatitis With Topical Naltrexone Naltrexone, Placebo Cream - Atopic Dermatitis, Pruritus | Phase 2 | Withdrawn | University of Minnesota | 2020-10-01 | 2021-04-20 | |
| Late Phase Administration Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation Anakinra, Anakinra Matching Placebo, Dermatophagoides Farinae - Asthma | Phase 1 / Phase 2 | Withdrawn | University of North Carolina, Chapel Hill | 2020-09-01 | 2021-05-14 |
Showing 20 of 81. Sign in to see all of them.
Asthma (41) · Dermatitis, Atopic (8) · Chronic Urticaria (4) · Peanut Hypersensitivity (4) · Rhinitis, Allergic (4) · Sarcoidosis (4) · Stevens-Johnson Syndrome (4) · Angioedemas, Hereditary (3) · Conjunctivitis, Allergic (3) · Pruritus (3) · Conjunctivitis (2) · Dermatitis (2) · Eczema (2) · Eosinophilic Esophagitis (2)
Immune System Diseases (80) · Hypersensitivity, Immediate (71) · Respiratory Tract Diseases (46) · Respiratory Hypersensitivity (45) · Lung Diseases (43) · Bronchial Diseases (40) · Lung Diseases, Obstructive (40) · Skin Diseases (21) · Skin and Connective Tissue Diseases (21) · Pathological Conditions, Signs and Symptoms (13) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (12) · Genetic Diseases, Inborn (11) · Dermatitis (10) · Hypersensitivity, Delayed (9)
Adalimumab (3) · Antigens, Dermatophagoides (3) · Infliximab (3) · Interleukin 1 Receptor Antagonist Protein (3) · Sodium Chloride (3) · montelukast (3) · Albuterol (2) · Allergens (2) · Naltrexone (2) · Receptors, Interleukin-6 (2) · 2-hydroxy-N,N-dimethyl-3-(2-((1-(5-methylfuran-2-yl)propyl)amino)-3,4-dioxocyclobut-1-enylamino)benzamide (1) · 3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole (1) · Aging (1) · Beclomethasone (1) · CXA-10 (1)
GlaxoSmithKline (4) · University of North Carolina, Chapel Hill (4) · Boehringer Ingelheim (3) · Novartis Pharmaceuticals (3) · University of California, Davis (2) · University of Chicago (2) · University of Minnesota (2) · AO GENERIUM (1) · Abbott (1) · Acerus Pharmaceuticals Corporation (1) · Ahuva D Cices (1) · Alcon Research (1) · Antigen Laboratories, Inc. (1) · AstraZeneca (1) · Bausch & Lomb Incorporated (1)
United States (32) · Canada (2) · France (1) · Germany (1) · Mexico (1) · Russia (1) · Spain (1) · United Kingdom (1)
James Chodosh, MD, MPH (2) · Michelle Hernandez, MD (2) · Paul Bigliardi, MD (2) · Ahuva Cices, MD (1) · Beverly Paperiello (1) · Blanca Camoretti-Mercado, Ph.D. (1) · Bryan Martin, DO (1) · Christopher Hull, MD (1) · Claes H Dohlman, MD, PhD (1)
PMID 26297574, PMID 28639856, PMID 34404358
R01HL135235 (3), 2009 (2), 2008 (1), 2014 (1), UL1RR024999 (1)